In The News: New Treatment for Dust Allergies

LUBBOCK, TX (KCBD) -
About 20 million Americans are allergic to dust mites. Those annoying little critters collect in the home, especially in mattresses and bedding, because they feed off the skin we shed.

That's the bad news. The good news is that the Food and Drug Administration has approved a breakthrough treatment to fight dust allergies.

It's called Odactra.

Dr. James Tarbox, an Allergist and Texas Tech Physician, says, "This is the first one in America for dust mites. So, it is a big deal."


This treatment is not an injection. It's much easier than that. Instead, Dr. Tarbox says this is a prescription you can take in your own home. He explains, "And what you do is you put it under your tongue and it will dissolve every day and after about 8 to 12 weeks, most people will notice a significant improvement in their symptoms."

Dust mite allergies are so common that he says, "20 to 30% of people with allergies are allergic to dust mites." He says it is also good to know that this new treatment has minor, if any side effects. Dr. Tarbox says patients may feel a little itching inside the mouth on the tongue, but nothing serious.

No word yet on when Odactra will be available since it was just FDA approved today on March 2nd.

In the meantime, Dr. Tarbox says you can reduce your reaction to dust by washing your bedding in hot water at least once a week.

And choose pillows that contain synthetics... rather than feathers.... because dust mites love feathers.

We have much more from Dr. Tarbox on preventing allergies. Just watch our special interview here.

Related Stories

TTUHSC’s Graduate School of Biomedical Sciences Hosts Student Research Week

The Texas Tech University Health Sciences Center (TTUHSC) Graduate School of Biomedical Sciences hosted its 34th Annual Student Research Week March 8-11.

TTUHSC Researcher Receives NIH Grant to Study Vulnerabilities in Specific Cancer Types

The National Cancer Institute awarded a five-year, $1.9 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at TTUHSC.

The Hype Around Artificial Intelligence

Richard Greenhill, DHA, FISQua, FACHE, discusses the hype and reality surrounding AI in healthcare.

Recent Stories

Health

Breastfeeding in a Formula Crisis

TTUHSC Assistant Professor of Pediatrics Christine Garner, Ph.D., R.D., says if your baby's normal brand of formula isn't available, you can swap it out for a different one.

Education

The First Patient: TTUHSC Students Gain Life-long Knowledge From Willed Body Program

The Willed Body Program has served West Texas since 1972 and is the foundation upon which the TTUHSC Institute of Anatomical Sciences is built.

Education

TTUHSC Class of 2022 Honored at Commencement Ceremonies

The Texas Tech University Health Sciences Center (TTUHSC) recently hosted traditional commencement ceremonies for its 1,595-member Class of 2022.